Maria Andersson

Brief report: enhancement of patient recruitment in rheumatoid arthritis clinical trials using a multi-biomarker disease activity score as an inclusion criterion.

van Vollenhoven RF, Bolce R, Hambardzumyan K, Saevarsdottir S, Forslind K, Petersson IF, Sasso EH, Hwang CC, Segurado OG, Geborek P. Arthritis Rheumatol. 2015 Nov;67(11):2855-60.

Genetic Factors for the Severity of ACPA-negative Rheumatoid Arthritis in 2 Cohorts of Early Disease: A Genome-wide Study.

de Rooy DP, Tsonaka R, Andersson ML, Forslind K, Zhernakova A, Frank-Bertoncelj M, de Kovel CG, Koeleman BP, van der Heijde DM, Huizinga TW, Toes RE, Houwing-Duistermaat JJ, Ospelt C, Svensson B, van der Helm-van Mil AH. J Rheumatol. 2015 Aug;42(8):1383-91.

Comparing Five Year Out-Come in Two Cohorts of Patients with Early Rheumatoid Arthritis - A BARFOT Study.

Andersson ML, Forslind K, Hafström I. Open Rheumatol J. 2015 Feb 3;9:8-15.

Smoking as a risk factor for the radiological severity of rheumatoid arthritis: a study on six cohorts.

de Rooy DP, van Nies JA, Kapetanovic MC, Kristjansdottir H, Andersson ML, Forslind K, van der Heijde DM, Gregersen PK, Lindqvist E, Huizinga TW, Gröndal G, Svensson B, van der Helm-van Mil AH. Ann Rheum Dis. 2014 Jul;73(7):1384-7.

Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis.

Andersson ML, Svensson B, Petersson IF, Hafström I, Albertsson K, Forslind K, Heinegård D, Saxne T. BMC Musculoskelet Disord. 2013 Aug 2;14:229.